• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Epithelial transport in digestive diseases: mice, monolayers, and mechanisms.消化疾病中的上皮转运:小鼠、单层细胞和机制。
Am J Physiol Cell Physiol. 2020 Jun 1;318(6):C1136-C1143. doi: 10.1152/ajpcell.00015.2020. Epub 2020 Apr 15.
2
Decreased SLC26A3 expression and function in intestinal epithelial cells in response to infection.感染导致肠道上皮细胞中 SLC26A3 的表达和功能下降。
Am J Physiol Cell Physiol. 2019 Dec 1;317(6):C1205-C1212. doi: 10.1152/ajpcell.00278.2019. Epub 2019 Sep 4.
3
Activation of Nuclear Factor-κB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.肿瘤坏死因子在肠上皮细胞和小鼠肠上皮中激活核因子-κB可降低氯离子转运体SLC26A3的表达。
Gastroenterology. 2017 Nov;153(5):1338-1350.e3. doi: 10.1053/j.gastro.2017.08.024. Epub 2017 Aug 18.
4
Diarrhoeal pathogenesis in Salmonella infection may result from an imbalance in intestinal epithelial differentiation through reduced Notch signalling.沙门氏菌感染导致腹泻的发病机制可能是由于Notch信号通路减弱,肠道上皮分化失衡所致。
J Physiol. 2022 Apr;600(8):1851-1865. doi: 10.1113/JP282585. Epub 2022 Feb 16.
5
Potentiation of calcium-activated chloride secretion and barrier dysfunction may underlie EGF receptor tyrosine kinase inhibitor-induced diarrhea.钙激活氯离子分泌和屏障功能障碍的增强可能是表皮生长因子受体酪氨酸激酶抑制剂诱导腹泻的基础。
Physiol Rep. 2020 Jul;8(13):e14490. doi: 10.14814/phy2.14490.
6
All-trans Retinoic Acid Counteracts Diarrhea and Inhibition of Downregulated in Adenoma Expression in Gut Inflammation.全反式维甲酸可对抗腹泻并抑制腺瘤中下调表达在肠道炎症中的作用。
Inflamm Bowel Dis. 2020 Mar 4;26(4):534-545. doi: 10.1093/ibd/izz249.
7
Interferon-γ alters downstream signaling originating from epidermal growth factor receptor in intestinal epithelial cells: functional consequences for ion transport.干扰素-γ改变肠上皮细胞中表皮生长因子受体的下游信号转导:对离子转运的功能影响。
J Biol Chem. 2012 Jan 13;287(3):2144-55. doi: 10.1074/jbc.M111.318139. Epub 2011 Nov 8.
8
Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.艰难梭菌毒素 A 和 B 降低肠道 SLC26A3 蛋白表达。
Am J Physiol Gastrointest Liver Physiol. 2018 Jul 1;315(1):G43-G52. doi: 10.1152/ajpgi.00307.2017. Epub 2018 Mar 29.
9
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.肠上皮钾通道和 CFTR 氯通道在表皮生长因子受体酪氨酸激酶抑制剂相关性腹泻中被激活。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.126444.
10
Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.嗜酸乳杆菌可对抗NHE3和DRA表达的抑制,并减轻感染啮齿柠檬酸杆菌小鼠的腹泻表型。
Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G817-G826. doi: 10.1152/ajpgi.00173.2016. Epub 2016 Sep 15.

引用本文的文献

1
Flow-induced mechano-modulation of intestinal permeability on chip.芯片上流动诱导的肠道通透性机械调节
Mater Today Bio. 2025 Jun 6;33:101951. doi: 10.1016/j.mtbio.2025.101951. eCollection 2025 Aug.
2
Mechanism and treatment of diarrhea associated with tyrosine kinase inhibitors.酪氨酸激酶抑制剂相关腹泻的机制与治疗
Heliyon. 2024 Mar 6;10(6):e27531. doi: 10.1016/j.heliyon.2024.e27531. eCollection 2024 Mar 30.
3
A Novel Peptide Prevents Enterotoxin- and Inflammation-Induced Intestinal Fluid Secretion by Stimulating Sodium-Hydrogen Exchanger 3 Activity.一种新型肽通过刺激钠-氢交换体 3 活性来预防肠毒素和炎症引起的肠道液体分泌。
Gastroenterology. 2023 Oct;165(4):986-998.e11. doi: 10.1053/j.gastro.2023.06.028. Epub 2023 Jul 8.
4
SLC26A3 (DRA) is stimulated in a synergistic, intracellular Ca-dependent manner by cAMP and ATP in intestinal epithelial cells.SLC26A3(DRA)在肠道上皮细胞中,通过 cAMP 和 ATP 以协同、细胞内 Ca2+依赖的方式被激活。
Am J Physiol Cell Physiol. 2023 Jun 1;324(6):C1263-C1273. doi: 10.1152/ajpcell.00523.2022. Epub 2023 May 8.
5
In Vitro Methods for Measuring the Permeability of Cell Monolayers.测量细胞单层通透性的体外方法
Methods Protoc. 2022 Feb 9;5(1):17. doi: 10.3390/mps5010017.
6
The Use of Traditional Chinese Medicine in Relieving EGFR-TKI-Associated Diarrhea Based on Network Pharmacology and Data Mining.基于网络药理学和数据挖掘的中药缓解表皮生长因子受体酪氨酸激酶抑制剂相关性腹泻的应用
Evid Based Complement Alternat Med. 2021 Apr 1;2021:5530898. doi: 10.1155/2021/5530898. eCollection 2021.

本文引用的文献

1
Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.酪氨酸激酶抑制剂治疗 EGFR 突变阳性非小细胞肺癌:代际冲突。
Clin Lung Cancer. 2020 May;21(3):e216-e228. doi: 10.1016/j.cllc.2019.12.003. Epub 2019 Dec 20.
2
The characterization, management, and future considerations for ErbB-family TKI-associated diarrhea.表皮生长因子受体家族 TKI 相关腹泻的特征、管理和未来考虑。
Breast Cancer Res Treat. 2019 May;175(1):5-15. doi: 10.1007/s10549-018-05102-x. Epub 2019 Jan 22.
3
Intestinal epithelial potassium channels and CFTR chloride channels activated in ErbB tyrosine kinase inhibitor diarrhea.肠上皮钾通道和 CFTR 氯通道在表皮生长因子受体酪氨酸激酶抑制剂相关性腹泻中被激活。
JCI Insight. 2019 Feb 21;4(4). doi: 10.1172/jci.insight.126444.
4
Organoid and Enteroid Modeling of Infection.类器官和肠类器官感染模型建立。
Front Cell Infect Microbiol. 2018 Apr 4;8:102. doi: 10.3389/fcimb.2018.00102. eCollection 2018.
5
Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR-Mutated Non-Small Cell Lung Cancer.表皮生长因子受体酪氨酸激酶抑制剂相关治疗毒性风险:吉非替尼、厄洛替尼和阿法替尼治疗晚期表皮生长因子受体突变型非小细胞肺癌临床试验的荟萃分析。
J Thorac Oncol. 2017 Apr;12(4):633-643. doi: 10.1016/j.jtho.2016.11.2236. Epub 2016 Dec 19.
6
Human mini-guts: new insights into intestinal physiology and host-pathogen interactions.人类微型肠道:对肠道生理学和宿主-病原体相互作用的新见解。
Nat Rev Gastroenterol Hepatol. 2016 Nov;13(11):633-642. doi: 10.1038/nrgastro.2016.142. Epub 2016 Sep 28.
7
Lactobacillus acidophilus counteracts inhibition of NHE3 and DRA expression and alleviates diarrheal phenotype in mice infected with Citrobacter rodentium.嗜酸乳杆菌可对抗NHE3和DRA表达的抑制,并减轻感染啮齿柠檬酸杆菌小鼠的腹泻表型。
Am J Physiol Gastrointest Liver Physiol. 2016 Nov 1;311(5):G817-G826. doi: 10.1152/ajpgi.00173.2016. Epub 2016 Sep 15.
8
Physiology of Intestinal Absorption and Secretion.肠道吸收与分泌的生理学
Best Pract Res Clin Gastroenterol. 2016 Apr;30(2):145-59. doi: 10.1016/j.bpg.2016.02.007. Epub 2016 Feb 10.
9
World Health Organization Global Estimates and Regional Comparisons of the Burden of Foodborne Disease in 2010.世界卫生组织《2010年食源性疾病负担的全球估计和区域比较》
PLoS Med. 2015 Dec 3;12(12):e1001923. doi: 10.1371/journal.pmed.1001923. eCollection 2015 Dec.
10
Mechanisms of DRA recycling in intestinal epithelial cells: effect of enteropathogenic E. coli.肠道上皮细胞中DRA回收机制:肠致病性大肠杆菌的影响
Am J Physiol Cell Physiol. 2015 Dec 15;309(12):C835-46. doi: 10.1152/ajpcell.00107.2015. Epub 2015 Oct 7.

消化疾病中的上皮转运:小鼠、单层细胞和机制。

Epithelial transport in digestive diseases: mice, monolayers, and mechanisms.

机构信息

Department of Medicine, University of California San Diego School of Medicine, La Jolla, California.

出版信息

Am J Physiol Cell Physiol. 2020 Jun 1;318(6):C1136-C1143. doi: 10.1152/ajpcell.00015.2020. Epub 2020 Apr 15.

DOI:10.1152/ajpcell.00015.2020
PMID:32293934
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7311737/
Abstract

The transport of electrolytes and fluid by the intestinal epithelium is critical in health to maintain appropriate levels of fluidity of the intestinal contents. The transport mechanisms that underlie this physiological process are also subject to derangement in various digestive disease states, such as diarrheal illnesses. This article summarizes the 2019 Hans Ussing Lecture of the Epithelial Transport Group of the American Physiological Society and discusses some pathways by which intestinal transport is dysregulated, particularly in the setting of infection with the diarrheal pathogen, , and in patients treated with small-molecule inhibitors of the tyrosine kinase activity of the epidermal growth factor receptor (EGFr-TKI). The burdensome diarrhea in patients infected with may be attributable to decreased expression of the chloride-bicarbonate exchanger downregulated in adenoma (DRA) that participates in electroneutral NaCl absorption. This outcome is possibly secondary to increased epithelial proliferation and/or decreased epithelial differentiation that occurs following infection. Conversely, the diarrheal side effects of cancer treatment with EGFr-TKI may be related to the known ability of EGFr-associated signaling to reduce calcium-dependent chloride secretion. Overall, the findings described may suggest targets for therapeutic intervention in a variety of diarrheal disease states.

摘要

肠道上皮细胞对电解质和液体的转运对于维持肠道内容物的适当流动性至关重要。这种生理过程的转运机制也会在各种消化疾病状态下发生紊乱,例如腹泻病。本文总结了美国生理学会上皮转运组 2019 年 Hans Ussing 讲座的内容,并讨论了一些肠道转运失调的途径,特别是在感染腹泻病原体 和接受表皮生长因子受体(EGFr-TKI)酪氨酸激酶活性小分子抑制剂治疗的患者中。感染 后,腺瘤下调的氯离子碳酸氢根交换体(DRA)表达减少,导致患者出现负担沉重的腹泻,这可能参与了电中性的 NaCl 吸收。这种结果可能继发于感染后发生的上皮细胞过度增殖和/或上皮细胞分化减少。相反,EGFr-TKI 治疗癌症引起的腹泻副作用可能与已知的 EGFr 相关信号转导减少钙依赖性氯离子分泌的能力有关。总的来说,这些发现可能提示针对各种腹泻疾病状态的治疗干预靶点。